APA (7th ed.) Citation

Jiang, Y., Jia, Z., Zheng, Z., Liao, Y., Zhao, Q., Lin, W., . . . Ye, B. (2026). Cardiomyocyte‐enriched OTUD5 alleviates septic cardiomyopathy by promoting NLRP3 deubiquitination and inhibiting NLRP3 inflammasome activation. Clinical & Translational Medicine, 16(7), 1. https://doi.org/10.1002/ctm2.70743

Chicago Style (17th ed.) Citation

Jiang, Yucheng, et al. "Cardiomyocyte‐enriched OTUD5 Alleviates Septic Cardiomyopathy by Promoting NLRP3 Deubiquitination and Inhibiting NLRP3 Inflammasome Activation." Clinical & Translational Medicine 16, no. 7 (2026): 1. https://doi.org/10.1002/ctm2.70743.

MLA (9th ed.) Citation

Jiang, Yucheng, et al. "Cardiomyocyte‐enriched OTUD5 Alleviates Septic Cardiomyopathy by Promoting NLRP3 Deubiquitination and Inhibiting NLRP3 Inflammasome Activation." Clinical & Translational Medicine, vol. 16, no. 7, 2026, p. 1, https://doi.org/10.1002/ctm2.70743.